SciELO - Scientific Electronic Library Online

 
vol.7 número4Outcomes of babies born before arrival at a tertiary hospital in Johannesburg, South AfricaRespiratory outcomes following 100 mg/kg v. 200 mg/kg of poractant alpha: A retrospective review índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


South African Journal of Child Health

versão On-line ISSN 1994-3032

Resumo

TOOKE, L J; BROWDE, K  e  HARRISON, M C. Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting. S. Afr. j. child health [online]. 2013, vol.7, n.4, pp. 146-147. ISSN 1994-3032.

BACKGROUND: Methylxanthines such as caffeine have been proven to reduce apnoea of prematurity and are often discontinued at 35 weeks' corrected gestational age (GA). OBJECTIVE: To ascertain whether a caffeine protocol based on international guidelines is applicable in our setting, where GA is often uncertain. METHODS: A prospective folder review was undertaken of all premature infants discharged home over a 2-month period. RESULTS: Fifty-five babies were included. All babies born at less than 35 weeks' GA were correctly started on caffeine as per protocol. GA was assigned in 85.5% of cases by Ballard scoring and in 14.5% from antenatal ultrasound findings. Caffeine was discontinued before 35 weeks in 54.5%. DISCUSSION: The main reason for discontinuing caffeine early was the baby's ability to feed satisfactorily, a demonstration of physiological maturity. As feeding behaviours mature significantly between 33 and 36 weeks, the ability to feed may be a good indication that caffeine therapy can be stopped.

        · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License